Minimal Hepatic Encephalopathy: Clinical Trials

1 withdrawn. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Withdrawn 1

Follow Minimal Hepatic Encephalopathy: new trials by email Literature Review of Minimal Hepatic Encephalopathy trials Research Report on Minimal Hepatic Encephalopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Rifaximin - Cirrhosis, Liver, Minimal Hepatic Encephalopathy	Phase 3	Withdrawn	MetroHealth Medical Center		2021-09-15	2025-12-24

Narrower conditions

Liver Cirrhosis (1)

Broader conditions

Digestive System Diseases (1)  ·  Fibrosis (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Rifaximin (1)

Sponsors

MetroHealth Medical Center (1)

Top investigators

Ronnie Fass, MD (1)

Results publications

PMID 19302262, PMID 20675008, PMID 20849805, PMID 21157444, PMID 25932262, PMID 26644276